Pfizer’s Prevnar 20 protects against microorganisms that cause more than half of the invasive pneumococcal disease cases found in seniors — including bacteremia and meningitis, the company says.
Seniors with knee osteoarthritis had low rates of dedicated non-surgical care between 2005 and 2010, a new investigation reveals. Study findings suggest that surgery may often be used when conservative care is more appropriate, the author says.
Temperature and population density determine how easily the virus spreads — but only when localities have no mobility restrictions in place, a new study shows.
Operator changes plans, will wait for full FDA approval to enforce COVID vaccination deadline among staff … Colorado drops mask mandate for assisted living communities … FDA panel member resigns over Alzheimer’s drug approval … Trouble falling asleep may predict cognitive decline 14 years later … Comprehensive interventions may help psychotropic meds reduction in nursing homes, review shows … U.S. purchases Merck’s investigational COVID antiviral medicine
The steep declines in COVID-19 illness and mortality among the most vaccinated age group in the U.S. — seniors — demonstrate the potential impact of increasing vaccination coverage nationally, CDC researchers contend.
Finding a way to conduct COVID-19 testing among 31,000 residents and staff members across multiple states helped the senior living giant to “seal out” outbreaks and show that its communities were safe places to reside, says John Moore, CEO.
“Providing CNAs with information, resources, support, and opportunity will not only serve to improve vaccine receptivity, but may also have downstream benefits,” say geriatric nursing experts from Rory Meyers College of Nursing, New York University.
Twist in the FDA’s Alzheimer’s decision: no limits on which patients can get the drug … Biden administration advises changes to policies linked to N95 shortages … Frailty tied to increased mortality in COVID: A living review and meta-analysis … In type 1 diabetes, blood sugar extremes are tied to sixfold risk of dementia … Exercise likely to be best treatment for depression in coronary heart disease … “Immunological memory” protects against COVID re-infection for at least 11 months, analysis shows
An effective but arguably underused COVID-19 monoclonal antibody therapy now may be more accessible for long-term care facilities that aren’t equipped to deliver intravenous infusions.
The investigation was conducted before the FDA revoked emergency use of the drug — a monoclonal antibody — due to the impact of genetic variants on efficacy. But it still can be used in combination with etesevimab in most states.
